MedPath

Clinical Evaluation Gastrointestinal Motility With PillCam

Completed
Conditions
Gastrointestinal Motility
Interventions
Device: PillCam
Registration Number
NCT01158989
Lead Sponsor
University of Louisville
Brief Summary

The purpose of this study is to evaluate the clinical usefulness of a video camera pill (PillCam) in assessing intestinal function in the small intestines of patients. It is believed that the condition of the subjects digestive system can have a large impact on their overall physical health. Therefore, the investigators would like to assess whether using the pill device helps to determine any functional problems in patients in the ICU. The investigators are studying ICU patients because any change in their condition can have a large impact on their recovery. The same device will be used in healthy subjects scheduled for elective ambulatory surgery.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • mild-to-moderate brain injury patients who suffered from traumatic or non-traumatic intracranial hemorrhage
  • admitted to an intensive care unit (ICU)
  • needed an enteral tube placed for feeding
  • control (ambulatory) group consisted of outpatients with no history of major abdominal surgery
Exclusion Criteria
  • younger than 18 years
  • suffered multiple injuries (especially abdominal trauma or inflammatory bowel disease)
  • had a history of complicated or unknown abdominal surgery
  • presented with clinical evidence of ileus or suspected obstruction
  • Patients with a pacemaker

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Ambulatory GroupPillCamSubjects were scheduled for an outpatient procedure but were otherwise healthy
Critically illPillCamCritically ill subjects were intubated, mechanically ventilated and sedated
Primary Outcome Measures
NameTimeMethod
small bowel transit times8 hours

Small bowel transit time was calculated by measuring the difference between the start-time (i.e., placement of the capsule in the duodenum) and end-time (i.e., capsule enters the cecum). Examination of the differences between subsequent images indicates the amount of capsule movement and is proportional to the instant velocity ("motility") of the capsule

Secondary Outcome Measures
NameTimeMethod
visualization8 hours

The quality of the visualization was determined using a three-step scale: Grade 0: intraluminal fluid disturbed visualization and significantly impaired interpretation: grade 1: intraluminal fluid present but did not impair visualization or interpretation; grade 2: no intraluminal fluid, excellent visualization

Trial Locations

Locations (1)

University of Louisville Hospital

🇺🇸

Louisville, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath